AstraZeneca’s (AZN) “Buy” Rating Reaffirmed at Shore Capital
Shore Capital restated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report published on Thursday, MarketBeat.com reports. A number of other equities analysts have also weighed in on AZN. JPMorgan Chase & Co. restated an “overweight” rating on shares of AstraZeneca in a research note on Monday, September […]
Fortrea (NASDAQ:FTRE) Given Market Perform Rating at William Blair
Fortrea (NASDAQ:FTRE – Get Free Report)‘s stock had its “market perform” rating reissued by equities researchers at William Blair in a research report issued on Friday,Benzinga reports. A number of other equities research analysts also recently issued reports on FTRE. The Goldman Sachs Group cut their price objective on shares of Fortrea from $26.00 to […]
StockNews.com Initiates Coverage on Vista Outdoor (NYSE:VSTO)
StockNews.com began coverage on shares of Vista Outdoor (NYSE:VSTO – Free Report) in a research note released on Thursday morning. The firm issued a buy rating on the stock. Several other equities analysts have also issued reports on VSTO. Monness Crespi & Hardt lowered Vista Outdoor from a “buy” rating to a “neutral” rating in […]
TTEC (NASDAQ:TTEC) Upgraded to Hold at StockNews.com
TTEC (NASDAQ:TTEC – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Thursday. A number of other equities analysts have also commented on the stock. Canaccord Genuity Group decreased their price objective on shares of TTEC from $8.00 to $4.50 […]
StockNews.com Upgrades Infinera (NASDAQ:INFN) to “Hold”
Infinera (NASDAQ:INFN – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Thursday. Other equities analysts have also recently issued reports about the stock. B. Riley lowered their price target on shares of Infinera from $9.00 to $6.65 and set a […]
last updated on 8 Nov 21:48